Immune checkpoint therapy, particularly anti-PD-1/PD-L1 immunotherapy, have achieved significant results in the treatment of various tumors. However, most cancer patients show a low response rate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback